삼성서울병원

Ko En

Ju, Hee Young M.D

Expertise
Leukemia, lymphoma, anemia, hematopoietic stem cell transplantation, CAR-T cell therapy
Treament Schedule 05 月
DATE
THU
01
FRI
02
SAT
03
SUN
04
MON
05
TUE
06
WEB
07
THU
08
FRI
09
SAT
10
SUN
11
MON
12
TUE
13
WEB
14
THU
15
FRI
16
SAT
17
SUN
18
MON
19
TUE
20
WEB
21
THU
22
FRI
23
SAT
24
SUN
25
MON
26
TUE
27
WEB
28
THU
29
FRI
30
SAT
31
AM
PM
Treament Schedule 06 月
DATE
SUN
01
MON
02
TUE
03
WEB
04
THU
05
FRI
06
SAT
07
SUN
08
MON
09
TUE
10
WEB
11
THU
12
FRI
13
SAT
14
SUN
15
MON
16
TUE
17
WEB
18
THU
19
FRI
20
SAT
21
SUN
22
MON
23
TUE
24
WEB
25
THU
26
FRI
27
SAT
28
SUN
29
MON
30
AM
PM

Medical Education

2014~2021 Ph.D. in Medicine Seoul National University, Seoul, Korea
2012~2014 Master of Science Seoul National University, Seoul, Korea
2005~2009 College of Medicine, Seoul National University, Korea
2000~2005 College of Natural Sciences, Seoul National University, Korea

Post-Graduate Training

Fellowship   2015~2016 Center for Pediatric Oncology, National Cancer Center, Korea
2014~2015 Division of Pediatric Hematology/Oncology, Seoul National University Hospital, Korea
Residency   2010~2014 Department of Pediatrics, Seoul National University Hospital, Korea
Internship   2009~2010 Seoul National University Hospital, Korea

Professional Appointments

2022~Present Clinical Instructor Division of Pediatric Hematology/Oncology, Samsung Medical Center
2018~2022 Staff Hospitalist Division of Pediatric Hematology/Oncology, Samsung Medical Center
2017~2018 Associate Scientist Cancer Survivorship Branch, National Cancer Center
2016~2017 Clinical Staff Specialist Division of Pediatric Hematology/Oncology, National Cancer Center

Professional Memberships

2011~Present Member The Korean Society of Pediatric Hematology-Oncology
2014~Present Member The Korean Society of Hematology
2014~Present Member The Korean Society of Blood and Marrow Transplantation
2014~Present Member The Korean Pediatric Society

Selected Publications

  • PEDIATR HEMAT ONCOL 2025 10.1080/08880018.2025.2463927 Comparative analysis of a novel next-generation sequencing-based IGH clonality assay for measurable residual disease detection in pediatric B-cell acute lymphoblastic leukemia patients Park, MS; Ju, HY; Lee, JW; Yoo, KH; Kim, HJ; Cho, DC; Kim, HY
    View PubMed
  • FRONT IMMUNOL 2025 10.3389/fimmu.2025.1517387 Predicted indirectly recognizable HLA epitopes scores and clinical outcomes after haploidentical stem cell transplantation in pediatric patients with relapsed neuroblastoma Seo, ES; Jeong, IH; Ju, HY; Hyun, JK; Lee, JW; Yoo, KH; Heo, WY; Sung, KW; Cho, HW; Kang, ES
    View PubMed
  • CANCER RES TREAT 2025 10.4143/crt.2024.155 The Effect of Hematopoietic Stem Cell Transplantation on Treatment Outcome in Children with Acute Lymphoblastic Leukemia Ju, HY; Lee, NH; Yi, ES; Choi, YB; Kim, SJ; Hyun, JK; Cho, HW; Lee, JK; Lee, JW; Sung, KW; Koo, HH; Yoo, KH
    View PubMed
  • J VASC SURG-VENOUS L 2025 10.1016/j.jvsv.2024.101964 Multidisciplinary approach to hand arteriovenous malformations: Treatment strategies and clinical outcomes - insights from a 25-year experience at a single vascular anomalies center Lee, YD; Lee, SY; Kim, DI; Park, KB; Yang, SS; Park, YJ; Lim, SY; Hwang, JH; Yoo, KH; Ju, HY; Do, YS
    View PubMed
  • NAT COMMUN 2024 10.1038/s41467-024-52128-5 Germline functional variants contribute to somatic mutation and outcomes in neuroblastoma Seo, ES; Lee, JW; Lim, J; Shin, S; Cho, HW; Ju, HY; Yoo, KH; Sung, KW; Park, WY
    View PubMed
  • EUR J PHARM SCI 2024 10.1016/j.ejps.2024.106878 Genetic polymorphisms and their association with methotrexate polyglutamates during maintenance treatment in Korean children and young adults with acute lymphoblastic leukemia Choi, R; Kim, MJ; Ju, HY; Lee, JW; Lee, SY
    View PubMed
  • PEDIATR BLOOD CANCER 2024 10.1002/pbc.31173 Response-adapted consolidation therapy strategy for patients with metastatic high-risk neuroblastoma: Results of the SMC NB-2014 study Seo, ES; Lee, JW; Cho, HW; Ju, HY; Cho, YS; Lee, S; Moon, SH; Yoo, KH; Lim, D; Sung, KW
    View PubMed
  • CANCER RES TREAT 2024 10.4143/crt.2023.999 Tandem High-Dose Chemotherapy Increases the Risk of Secondary Malignant Neoplasm in Pediatric Solid Tumors Lim, H; Im, M; Seo, ES; Cho, HW; Ju, HY; Yoo, KH; Cho, SY; Kim, JW; Lim, D; Sung, KW; Lee, JW
    View PubMed
  • J KOREAN MED SCI 2023 10.3346/jkms.2023.38.e230 Current Status and Physicians' Perspectives of Childhood Cancer Survivorship in Korea: A Nationwide Survey of Pediatric Hematologists/ Oncologists Lee, JW; Yeo, YH; Ju, HY; Cho, HW; Yoo, KH; Sung, KW; Koo, HH; Jeong, SM; Shin, DW; Baek, HJ; Kook, H; Chung, NG; Cho, B; Kim, YA; Park, HJ; Song, YM
    View PubMed
  • LEUKEMIA RES 2023 10.1016/j.leukres.2023.107070 Response to chemotherapy in juvenile myelomonocytic leukemia and its clinical implications for survival: A retrospective registry-based study of the Korean Pediatric Hematology-Oncology Group Yi, ES; Baek, HJ; Ju, HY; Kim, SK; Lee, JW; Cho, B; Kim, BK; Kang, HJ; Kook, H; Yang, EJ; Lim, YT; Ahn, WK; Hahn, SM; Park, SK; Yoo, ES; Yoo, KH
    View PubMed
  • ANN LAB MED 2023 10.3343/alm.2023.43.2.204 The First Case of Acute Myeloid Leukemia With Underlying Fanconi Anemia due to FANCF Variants Suh, E; Shin, S; Ju, HY; Yoo, KH; Kim, HY; Cho, DC; Kim, SH; Kim, HJ
    View PubMed
  • CLIN IMMUNOL 2023 10.1016/j.clim.2023.109269 Minimal dose of hematopoietic stem cell transplantation without myelosuppressive conditioning for T-B plus NK- severe combined immunodeficiency Yi, ES; Ju, HY; Cho, HW; Lee, JW; Sung, KW; Koo, HH; Kang, ES; Ahn, KM; Kim, YJ; Yoo, KH
    View PubMed
  • PEDIATR BLOOD CANCER 2023 10.1002/pbc.30233 High-dose chemotherapy followed by autologous stem cell transplantation in pediatric patients with relapsed osteosarcoma Kang, SH; Kim, W; Lee, JS; Suh, JK; Kim, H; Kim, DK; Choi, SH; Cho, HW; Ju, HY; Yoo, KH; Sung, KW; Koo, HH; Seo, SW; Im, HJ; Lee, JW; Koh, KN
    View PubMed
  • BONE MARROW TRANSPL 2022 10.1038/s41409-022-01826-z Allogeneic hematopoietic cell transplantation in patients with juvenile myelomonocytic leukemia in Korea: a report of the Korean Pediatric Hematology-Oncology Group Yi, ES; Kim, SK; Ju, HY; Lee, JW; Cho, B; Kim, BK; Kang, HJ; Baek, HJ; Kook, H; Yang, EJ; Lim, YT; Ahn, WK; Hahn, SM; Park, SK; Yoo, ES; Yoo, KH
    View PubMed
  • SCI REP-UK 2022 10.1038/s41598-022-17246-4 Clinical significance of germline telomere length and associated genetic factors in patients with neuroblastoma Bae, JS; Lee, JW; Joung, JG; Cho, HW; Ju, HY; Yoo, KH; Koo, HH; Sung, KW
    View PubMed
  • PEDIATR BLOOD CANCER 2022 10.1002/pbc.29840 Postchemotherapy gross residual tumor in non-high-risk neuroblastoma: Clinical significance and the role of adjuvant therapy Seo, ES; Lim, H; Cho, HW; Ju, HY; Lee, JW; Yoo, KH; Lee, S; Lim, D; Sung, KW; Koo, HH
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.178 Vincristine, Irinotecan, and Temozolomide as a Salvage Regimen for Relapsed or Refractory Sarcoma in Children and Young Adults Ju, HY; Park, M; Lee, JA; Park, HJ; Park, SY; Kim, JH; Kang, HG; Yang, HC; Park, BK
    View PubMed
  • J PEDIAT HEMATOL ONC 2022 10.1097/MPH.0000000000002206 Safety and Efficacy of Pegteograstim on Chemotherapy-induced Neutropenia in Children and Adolescents With Solid Tumors Cho, HW; Lee, JW; Ju, HY; Hyun, JK; Yoo, KH; Koo, HH; Kim, K; Sung, KW
    View PubMed
  • J KOREAN MED SCI 2022 10.3346/jkms.2022.37.e59 Risk Stratification of Childhood Medulloblastoma Using Integrated Diagnosis: Discrepancies With Clinical Risk Stratification Cho, HW; Lee, H; Ju, HY; Yoo, KH; Koo, HH; Lim, DH; Sung, KW; Shin, HJ; Suh, YL; Lee, JW
    View PubMed
  • FRONT MED-LAUSANNE 2022 10.3389/fmed.2022.769221 The Positive Effects of Cancer Survivor Support Service on Distress in South Korea: A Nationwide Prospective Study Lee, HJ; Kim, YA; Ryu, SY; Chun, M; Yim, CY; Kang, HT; Kang, JH; Huh, JS; Kim, JH; Lim, KH; Jung, SY; Kwon, HC; Goh, E; Lee, YS; Ju, HY; Yun, EH; Chang, YJ
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.010 Absolute Neutrophil Count after the First Chemotherapy Cycle as a Surrogate Marker for Treatment Outcomes in Patients with Neuroblastoma Lee, JW; Bae, JS; Kim, JH; Cho, HW; Ju, HY; Yoo, KH; Koo, HH; Woo, SY; Kim, S; Sung, KW
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.313 Clinical Characteristics and Treatment Outcomes of Childhood Acute Promyelocytic Leukemia in Korea: A Nationwide Multicenter Retrospective Study by Korean Pediatric Oncology Study Group Park, KM; Yoo, KH; Kim, SK; Lee, JW; Chung, NG; Ju, HY; Koo, HH; Lyu, CJ; Han, SM; Han, JW; Choi, JY; Hong, KT; Kang, HJ; Shin, HY; Im, HJ; Koh, KN; Kim, H; Kook, H; Baek, HJ; Kim, BR; Yang, EJ; Lim, JY; Park, ES; Choi, EJ; Park, SK; Lee, JM; Shim, YJ; Kim, JY; Park, JK; Kong, SG; Choi, YB; Cho, B; Lim, YT
    View PubMed
  • PEDIATR BLOOD CANCER 2021 10.1002/pbc.29502 Clinical implication of residual MIBG-positive disease in the follow-up of high-risk neuroblastoma treated with tandem high-dose chemotherapy and autologous stem cell transplantation Seo, ES; Shin, M; Lim, H; Cho, HW; Ju, HY; Cho, YS; Yoo, KH; Koo, HH; Lee, JW; Sung, KW
    View PubMed
  • PloS one DNA-thioguanine nucleotide as a treatment marker in acute lymphoblastic leukemia patients with NUDT15 variant genotypes Hee Young Ju1, Ji Won Lee, Hee Won Cho, Ju Kyung Hyun, Youngeun Ma, Eun Sang Yi, Keon Hee Yoo, Ki Woong Sung, Rihwa Choi, Hong Hoe Koo, Soo-Youn Lee
    View PubMed
  • CANCER RESEARCH AND TREATMENT Vincristine, Irinotecan, and Temozolomide as a Salvage Regimen for Relapsed or Refractory Sarcoma in Children and Young Adults Hee Young Ju 1, Meerim Park, Jun Ah Lee, Hyeon Jin Park, Seog Yun Park, June Hyuk Kim, Hyun Guy Kang, Hee Chul Yang, Byung-Kiu Park
    View PubMed
  • J KOREAN MED SCI 2021 10.3346/jkms.2021.36.e128 Conditioning with 10 Gy Total Body Irradiation, Cyclophosphamide, and Fludarabine without ATG Is Associated with Improved Outcome of Cord Blood Transplantation in Children with Acute Leukemia Cho1, HW; Ju, HY; Hyun, JK; Lee, JW; Sung, KW; Koo, HH; Lim, DH; Yoo, KH
    View PubMed
  • ANN LAB MED 2021 10.3343/alm.2021.41.2.145 Quantification of Thioguanine in DNA Using Liquid Chromatography-Tandem Mass Spectrometry for Routine Thiopurine Drug Monitoring in Patients With Pediatric Acute Lymphoblastic Leukemia Choi1, R; Chun, MR; Park, J; Lee, JW; Ju, HY; Cho, HW; Hyun, JK; Koo, HH; Yi, ES; Lee, SY
    View PubMed
  • PLOS ONE 2021 10.1371/journal.pone.0245667 DNA-thioguanine nucleotide as a treatment marker in acute lymphoblastic leukemia patients with NUDT15 variant genotypes Ju1, HY; Lee, JW; Cho, HW; Hyun, JK; Ma, Y; Yi, ES; Yoo, KH; Sung, KW; Choi, R; Koo, HH; Lee, SY
    View PubMed
  • Oncology. 2020;98(2):81-90. doi: 10.1159/000502548. Epub 2019 Sep 11. Histologic Response and Toxicity Following Interval-Compressed Four-Drug Therapy Given Preoperatively in Children and Young Adults With Osteosarcoma: A Retrospective Study Ji-Man Kang 1 1, Hee Young Ju 1 , Jungnam Joo 2 , Jee Young Sung 3 , Seog Yun Park 4 , June Hyuk Kim 5 , Hyun Guy Kang 5 , Mimi Kwon 1 , Meerim Park 1 , Hyeon Jin Park 1 , Byung-Kiu Park 6 7
    View PubMed
  • J KOREAN MED SCI 2020 10.3346/jkms.2020.35.e393 Clinical Characteristics and Treatment Outcomes in Children, Adolescents, and Young-adults with Hodgkin's Lymphoma a KPHOG Lymphoma Working-party, Multicenter, Retrospective Study Lee1, JM; Choi, JY; Hong, KT; Kang, HJ; Shin, HY; Baek, HJ; Kook, H; Kim, S; Lee, JW; Chung, NG; Cho, B; Cho, SG; Park, KM; Yang, EJ; Lim, YT; Suh, JK; Kang, SH; Kim, H; Koh, KN; Im, HJ; Seo, JJ; Cho, HW; Ju, HY; Lee, JW; Yoo, KH; Sung, KW; Koo, HH; Park, KD; Hah, JO; Kim, MK; Han, JW; Hahn, SM; Lyu, CJ; Shim, YJ; Kim, HS; Do, YR; Yoo, JW; Lim, YJ; Jeon, IS; Chueh, HW; Oh, SY; Choi, HS; Park, JE; Lee, JA; Park, HJ; Park, BK; Kim, SK; Lim, JY; Park, ES; Park, SK; Choi, EJ; Choi, YB; Yoon, JH
    View PubMed
  • INT J RADIAT ONCOL 2020 10.1016/j.ijrobp.2020.05.051 Induction Chemotherapy Reduces Radiation Therapy Dose and Volume in the Treatment of Intracranial Germinoma Results of the SMC-G13 Trial Lee1, JW; Lim, D; Sung, KW; Cho, HW; Ju, HY; Yoo, KH; Koo, HH; Kim, JH; Suh, YL; Shin, HJ
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9092730 Metastatic Burden Defines Clinically and Biologically Distinct Subgroups of Stage 4 High-Risk Neuroblastoma Seo1, ES; Lee, EJ; Lee, B; Shin, M; Cho, YS; Hyun, JK; Cho, HW; Ju, HY; Yoo, KH; Koo, HH; Lee, JW; Sung, KW
    View PubMed
  • J KOREAN MED SCI 2020 10.3346/jkms.2020.35.e82 Clinical Significance of Segmental Chromosomal Aberrations in Patients with Neuroblastoma:First Report in Korean Population Lim1, H; Son, MH; Hyun, JK; Cho, HW; Ju, HY; Lee, JW; Yoo, KH; Sung, KW; Koo, HH
    View PubMed
  • PEDIATR BLOOD CANCER 2020 10.1002/pbc.28066 Predictors of survival in patients with high-risk neuroblastoma who failed tandem high-dose chemotherapy and autologous stem cell transplantation Yi1, ES; Son, MH; Hyun, JK; Cho, HW; Ju, HY; Lee, JW; Yoo, KH; Sung, KW; Koo, HH
    View PubMed
  • GENE CHROMOSOME CANC 2019 10.1002/gcc.22825 Molecular characteristics of terminal deoxynucleotidyl transferase negative precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement Yoon1, J; Yun, JW; Jung, CW; Ju, HY; Koo, HH; Kim, SH; Kim, HJ
    View PubMed
  • J KOREAN MED SCI 2019 10.3346/jkms.2019.34.e254 Differential Clinical Significance of Neurotrophin-3 Expression according to MYCN Amplification and TrkC Expression in Neuroblastoma Seo1, E; Kim, JS; Ma, YE; Cho, HW; Ju, HY; Lee, SH; Lee, JW; Yoo, KH; Sung, KW; Koo, HH
    View PubMed
  • BRIT J HAEMATOL 2019 10.1111/bjh.16242 Outcomes of acute lymphoblastic leukaemia in adolescent and young adult Korean patients Kim1, YA; Ju, HY; Park, HJ; Lee, NY; Lee, HJ; Lee, H; Ghang, H
    View PubMed
  • PLoS One. 2018 Nov 15;13(11):e0207243. doi: 10.1371/journal.pone.0207243. eCollection 2018. Second Malignant Neoplasms After Childhood Cancer: A Nationwide Population-Based Study in Korea Hee Young Ju 1 2 1, Eun-Kyeong Moon 3 , Jiwon Lim 3 , Byung Kiu Park 1 , Hee Young Shin 4 , Young-Joo Won 3 , Hyeon Jin Park 1
    View PubMed
  • Transpl Infect Dis. 2016 Jun;18(3):396-404. doi: 10.1111/tid.12539. Epub 2016 Jun 9. Half-dose Ganciclovir Preemptive Treatment of Cytomegalovirus Infection After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation H Y Ju 1 2 1, H J Kang 2 3 , C R Hong 2 3 , J W Lee 2 3 , H Kim 4 , K D Park 2 3 , H Y Shin 2 3 , J D Park 3 , E H Choi 3 , H J Lee 3 , H S Ahn 2 3
    View PubMed